Abstract:We have reported that epoxyeicosatrienoic acids (EETs), the cytochrome P450 (CYP) epoxygenase metabolites of arachidonic acid (AA), are potent sarcolemmal ATP-sensitive K+ (K-ATP) channel activators. However, activation of cardiac and vascular K-ATP channels by endogenously produced EETs under physiological intracellular conditions has not been demonstrated and direct comparison of the mechanisms whereby EETs activate the K-ATP channels in cardiac myocytes versus vascular smooth muscle cells has not been made. In this study, we examined the effects of AA on K-ATP channels in freshly isolated cardiac myocytes from rats, wild-type (WT) and transgenic mice overexpressing CYP2J2 cDNA, and mesenteric arterial smooth muscle cells from rats. We also compared the activation of cardiac and vascular K-ATP channels by extracellularly and intracellularly applied 11,12-EET. We found that 1 mu m AA enhanced K-ATP channel activities in both cardiac and vascular smooth muscle cells, and the AA effects were inhibited by preincubation with CYP epoxygenase inhibitors. Baseline cardiac K-ATP current densities in CYP2J2 transgenic mice were 190% higher than those of WT mice, and both were reduced to similar levels by CYP epoxygenase inhibition. Western blot analysis showed that expression of Kir6.2 and SUR2A was similar between WT and CYP2J2 transgenic hearts. 11,12-EET (5 mu m) applied intracellularly enhanced the K-ATP currents by 850% in cardiac myocytes, but had no effect in vascular smooth muscle cells. In contrast, 11,12-EET (5 mu m) applied extracellularly increased K-ATP currents by 520% in mesenteric arterial smooth muscle cells, but by only 209% in cardiac myocytes. Preincubation with 100 mu m m-iodobenzylguanidine or 5 mu m myristoylated PKI amide did not alter the activation of cardiac K-ATP channels by 5 mu m 11,12-EET, but significantly inhibited activation of vascular K-ATP channels. Moreover, EET only enhanced the inward component of cardiac K-ATP currents, but activated both the inward and outward components of vascular K-ATP currents. Our results indicate that endogenously derived CYP metabolites of AA potently activate cardiac and vascular K-ATP channels. EETs regulate cardiac electrophysiology and vascular tone by K-ATP channel activation, albeit through different mechanisms: the cardiac K-ATP channels are directly activated by EETs, whereas activation of the vascular K-ATP channels by EETs is protein kinase A dependent.

Vascular endothelial over-expression of soluble epoxide hydrolase (Tie2-sEH) enhances adenosine A1 receptor-dependent contraction in mouse mesenteric arteries: role of ATP-sensitive K+ channels

EET-dependent Potentiation of Pulmonary Arterial Pressure: Sex-Different Regulation of Soluble Epoxide Hydrolase.

A Soluble Epoxide Hydrolase Inhibitor—8-Hude Increases Pulmonary Vasoconstriction Through Inhibition of KATP Channels

Exploiting the Cellular Actions of Skca and Ikca Channels to Manipulate Endothelial Function and Vascular Tone

Soluble Epoxide Hydrolase is Involved in the Development of Atherosclerosis and Arterial Neointima Formation by Regulating Smooth Muscle Cell Migration.

Aberrant Endoplasmic Reticulum Stress in Vascular Smooth Muscle Increases Vascular Contractility and Blood Pressure in Mice Deficient of AMP-activated Protein Kinase-Α2 in Vivo.

Soluble Epoxide Hydrolase Inhibition Protected against Angiotensin II-induced Adventitial Remodeling

A Novel Role for Endothelial Katp Channels in Regulating Coronary Blood Vessel Tone

Soluble Epoxide Hydrolase Inhibitor t-AUCB Ameliorates Vascular Endothelial Dysfunction by Influencing the NF-κB/miR-155-5p/eNOS/NO/IκB Cycle in Hypertensive Rats

Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid.

Cardiac and Vascular K-Atp Channels in Rats Are Activated by Endogenous Epoxyeicosatrienoic Acids Through Different Mechanisms

Activation of rat mesenteric arterial K<sub>ATP</sub> channels by 11,12-epoxyeicosatrienoic acid

Angiotensin II Up-Regulates Soluble Epoxide Hydrolase in Vascular Endothelium in Vitro and in Vivo.

Sexually Dimorphic Phenotype of Arteriolar Responsiveness to Shear Stress in Soluble Epoxide Hydrolase-Knockout Mice

Mechanism of rat mesenteric arterial K<sub>ATP</sub> channel activation by 14,15-epoxyeicosatrienoic acid

Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid.

Tetramethylpyrazine Suppresses Angiotensin II-induced Soluble Epoxide Hydrolase Expression in Coronary Endothelium Via Anti-Er Stress Mechanism

Adenosine relaxation in isolated rat aortic rings and possible roles of smooth muscle Kv channels, KATP channels and A2a receptors

Cardiac and vascular K ATP channels in rats are activated by endogenous epoxyeicosatrienoic acids through different mechanisms: Activation of cardiac and vascular K ATP channels by EETs

Vascular Characterization of Mice with Endothelial Expression of Cytochrome P450 4F2.

CALL FOR PAPERS Regulation of Cardiovascular Functions by Eicosanoids and Other Lipid Mediators Mechanism of Rat Mesenteric Arterial KATP Channel Activation by 14,15-Epoxyeicosatrienoic Acid